Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Curaleaf Holdings Inc T.CURA

Alternate Symbol(s):  CURLF

Curaleaf Holdings, Inc. is an international provider of consumer cannabis products. The Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide selection and accessibility across the medical and adult use markets. It operates in approximately 17 states and owns and operates 147 dispensaries and 21 cultivation sites with a focus on states, including Arizona, Florida, Illinois, Massachusetts, New Jersey, New York and Pennsylvania. It cultivates, processes, markets and/or dispenses a range of permitted cannabis products across its operating markets, including flower and pre-rolls, dry-herb vaporizer cartridges, concentrates for vaporizing such as pre-filled vaporizer cartridges and disposable vaporizer pens, concentrates for dabbing, such as mints, topical balms and lotions, tinctures, lozenges, capsules and edibles. Through Curaleaf International Holdings Limited, it has a supply and distribution network throughout the European market.


TSX:CURA - Post by User

Comment by Bullknit101on Apr 04, 2023 10:45pm
95 Views
Post# 35380196

RE:Top Cannabis MSOs will Grow & Weather the Economic Storm

RE:Top Cannabis MSOs will Grow & Weather the Economic StormVery well said backspace. I wish I could share your enthusiasm and optimism. I feel the CSE Top Tier may be marginally better for Cura and re-scheduling timeline will be beyond this summer. The HHS clearly indicated that the DEA had the final say and I think that's where the risk lies. The DEA has bias against Cannabis.  Once we get the latest Q results, we'll know what we're dealing with. The sector has been so depressed for so long, it's hard to find a silver lining. 
<< Previous
Bullboard Posts
Next >>